UBS Group’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-243,434
Closed -$1.2M 9346
2025
Q1
$1.2M Buy
243,434
+18,845
+8% +$93.1K ﹤0.01% 4055
2024
Q4
$660K Buy
224,589
+201,043
+854% +$591K ﹤0.01% 4524
2024
Q3
$111K Buy
23,546
+8,202
+53% +$38.7K ﹤0.01% 5092
2024
Q2
$59.1K Sell
15,344
-38,020
-71% -$146K ﹤0.01% 5418
2024
Q1
$285K Sell
53,364
-17,520
-25% -$93.7K ﹤0.01% 4476
2023
Q4
$303K Buy
70,884
+37,457
+112% +$160K ﹤0.01% 4329
2023
Q3
$131K Sell
33,427
-49,005
-59% -$192K ﹤0.01% 4554
2023
Q2
$834K Sell
82,432
-108,344
-57% -$1.1M ﹤0.01% 3440
2023
Q1
$1.95M Buy
190,776
+97,928
+105% +$999K ﹤0.01% 2627
2022
Q4
$870K Buy
92,848
+74,961
+419% +$702K ﹤0.01% 3256
2022
Q3
$261K Buy
17,887
+3,240
+22% +$47.3K ﹤0.01% 3864
2022
Q2
$194K Sell
14,647
-137,664
-90% -$1.82M ﹤0.01% 3968
2022
Q1
$2.6M Buy
152,311
+92,364
+154% +$1.58M ﹤0.01% 2455
2021
Q4
$1.54M Buy
+59,947
New +$1.54M ﹤0.01% 3093